By Paul McClure A clinical trial has shown that a rheumatoid arthritis drug can preserve the pancreas’ ability to produce insulin in newly diagnosed type 1 diabetics Depositphotos A world-first clinical trial has found that baricitinib, a drug commonly prescribed for rheumatoid arthritis, preserved the pancreatic cells’ ability to produce their own insulin and slowed the...
by Justin Jackson, Medical Xpress (a) Percentage Δ-change in C-peptide AUC (0–120 min) for the MMTT comparison between baseline (before treatment) and 12 months after treatment, at the day 372 visit. A comparison of participants treated in part A of the study (dose escalation study) was performed. Participants receiving high-dose ProTrans (n=3) demonstrated a maintenance...
